tert-Butyl 3-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate, 95.0%, 1g

2-Butyn-1-ol>98.0%(GC)5mL

1-(2-Fluorophenyl)-2-methylpropan-2-amine, 98%, 5g

6-Iodo-2(3H)-benzoxazolone, 95%, 5g

Zernike phase contrast set PLPHi 10/20/40/100 IOS bright field and dark field position

Vinyl terminated diphenylsiloxane-dimethylsiloxane copolymer cSt 4000-5000, 100g

4-Phenylthiomorpholine 1,1-dioxide, 98+%, 1g

2-Iodo-3,5-dimethylphenol, 98%, 5g

2'-AZIDO-2'-DEOXYURIDINE, 95.0%, 1g

1H,1H-Pentafluoropropyl acrylate contains 100 ppm 4-tert-butylcatechol as inhibitor, 97.0%, 25g

Methyl 1H-pyrrolo[3,2-b]pyridine-6-carboxylate, 95.0%, 100mg

3-Phenoxypyridine, 95.0%, 250mg

4-((5-(BENZYLOXY)-2-BROMOPHENOXY)METHYL)PYRIDINE, 90.0%, 100mg